+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2022 Update

  • PDF Icon

    Company Profile

  • 44 Pages
  • February 2023
  • Region: Global
  • GlobalData
  • ID: 5739999
Proteomics International Laboratories Ltd (Proteomics) works as a medical technology organization that finds new biopharmaceutical drugs. It outfits its exclusive proteomics-based technology stage to work in three coordinated regions: diagnostics, logical services and medication revelation. Proteomics is the large-scale mapping of the structure and function of proteins. Proteomics created PromarkerD, a prescient test for the determination of diabetic kidney infection. Its logical services incorporate pharmacokinetic testing, biosimilars or biologic medication portrayal, and proteome planning. The organization chips away at the disclosure of pain relievers and anti-toxins drug compounds from creature toxin. It serves the drug business across Australia. The company is headquartered in Nedlands, Western Australia, Australia.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Proteomics International Laboratories Ltd
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • Proteomics International Laboratories Ltd Company Overview
  • Proteomics International Laboratories Ltd Company Snapshot
  • Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Proteomics International Laboratories Ltd - Pipeline Analysis Overview
  • Proteomics International Laboratories Ltd - Key Facts
  • Proteomics International Laboratories Ltd - Major Products and Services
  • Proteomics International Laboratories Ltd Pipeline Products by Development Stage
  • Proteomics International Laboratories Ltd Pipeline Products Overview
  • Diagnostic Test - Alzheimer's Disease
  • Diagnostic Test - Alzheimer's Disease Product Overview
  • Next Generation Diagnostic Test
  • Next Generation Diagnostic Test Product Overview
  • Promarker Test - Asthma And COPD
  • Promarker Test - Asthma And COPD Product Overview
  • Promarker Test - COVID-19
  • Promarker Test - COVID-19 Product Overview
  • Promarker Test - COVID-19 Dx
  • Promarker Test - COVID-19 Dx Product Overview
  • Promarker Test - Diabetic Retinopathy
  • Promarker Test - Diabetic Retinopathy Product Overview
  • Promarker Test - Endometriosis
  • Promarker Test - Endometriosis Product Overview
  • Promarker Test - Giardia
  • Promarker Test - Giardia Product Overview
  • Promarker Test - Mesothelioma
  • Promarker Test - Mesothelioma Product Overview
  • Promarker Test - Oesophageal Cancer
  • Promarker Test - Oesophageal Cancer Product Overview
  • Promarker Test - Oxidative Stress
  • Promarker Test - Oxidative Stress Product Overview
  • PromarkerD
  • PromarkerD Product Overview
  • PromarkerD (CDx)
  • PromarkerD (CDx) Product Overview
  • PromarkerD LDT
  • PromarkerD LDT Product Overview
  • Proteomics International Laboratories Ltd - Key Competitors
  • Proteomics International Laboratories Ltd - Key Employees
  • Proteomics International Laboratories Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
  • Recent Developments
  • Proteomics International Laboratories Ltd, Recent Developments
  • Jun 21, 2022: Proteomics secures licence to commercialise QIMR’s cancer biomarkers
  • May 18, 2021: Proteomics International secures major analytical services contract in pharmacokinetic testing
  • May 18, 2021: Proteomics secures major analytical services contract
  • May 25, 2020: Proteomics International receives COVID-19 research grants
  • Apr 07, 2020: Proteomics International: The Promarker Pipeline
  • Jan 14, 2020: CE mark for PromarkerD Hub
  • Nov 12, 2019: Proteomics International achieves CE Mark for world's first predictive test for diabetic kidney disease PromarkerD (MS)
  • Oct 31, 2019: Proteomics International: Quarterly Business Update
  • Oct 29, 2019: Proteomics International receives $1.1 million in R&D tax incentive
  • Sep 17, 2019: PromarkerD immunoassay In Vitro Diagnostic test (IVD) platform successfully developed and validated
  • Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Proteomics International Laboratories Ltd Pipeline Products and Ongoing Clinical Trials Overview
  • Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
  • Proteomics International Laboratories Ltd Pipeline Products by Indication
  • Proteomics International Laboratories Ltd, Key Facts
  • Proteomics International Laboratories Ltd, Major Products and Services
  • Proteomics International Laboratories Ltd Number of Pipeline Products by Development Stage
  • Proteomics International Laboratories Ltd Pipeline Products Summary by Development Stage
  • Diagnostic Test - Alzheimer's Disease - Product Status
  • Diagnostic Test - Alzheimer's Disease - Product Description
  • Next Generation Diagnostic Test - Product Status
  • Next Generation Diagnostic Test - Product Description
  • Promarker Test - Asthma And COPD - Product Status
  • Promarker Test - Asthma And COPD - Product Description
  • Promarker Test - COVID-19 - Product Status
  • Promarker Test - COVID-19 - Product Description
  • Promarker Test - COVID-19 Dx - Product Status
  • Promarker Test - COVID-19 Dx - Product Description
  • Promarker Test - Diabetic Retinopathy - Product Status
  • Promarker Test - Diabetic Retinopathy - Product Description
  • Promarker Test - Endometriosis - Product Status
  • Promarker Test - Endometriosis - Product Description
  • Promarker Test - Giardia - Product Status
  • Promarker Test - Giardia - Product Description
  • Promarker Test - Mesothelioma - Product Status
  • Promarker Test - Mesothelioma - Product Description
  • Promarker Test - Oesophageal Cancer - Product Status
  • Promarker Test - Oesophageal Cancer - Product Description
  • Promarker Test - Oxidative Stress - Product Status
  • Promarker Test - Oxidative Stress - Product Description
  • PromarkerD - Product Status
  • PromarkerD - Product Description
  • PromarkerD (CDx) - Product Status
  • PromarkerD (CDx) - Product Description
  • PromarkerD LDT - Product Status
  • PromarkerD LDT - Product Description
  • Proteomics International Laboratories Ltd, Key Employees
  • Proteomics International Laboratories Ltd, Other Locations
  • Glossary
List of Figures
  • Proteomics International Laboratories Ltd Pipeline Products by Equipment Type
  • Proteomics International Laboratories Ltd Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • INOVIQ Ltd
  • Medtronic Australasia Pty Ltd
  • AusBiotech Ltd